PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2008 2009
SUMMARY:
TASC II TB Project (TASC II TB), managed by University Research Co., LLC, works with all levels of
Department of Health (DOH) to increase screening, referral, treatment, and follow-up of TB and TB/HIV co-
infected patients. Activities are designed to improve TB/HIV coordinated activities at program management
and service delivery levels. TASC II TB provides support in development of operational policies and
capacity development in laboratory, clinical skills, and community outreach. At service delivery level,
emphasis is on integrating TB screening at HIV testing sites and vice versa as well as ensuring that TB/HIV
co-infected patients are put on appropriate treatment regimens as well as referred for ARV treatment and
follow-up services. Limited support is provided to community and home-based care groups to increase
awareness of TB/HIV coinfections and need for early screening and follow-up. Emphasis is on human
capacity development.
BACKGROUND:
This is an ongoing activity and is part of a larger USAID-funded TB project started in September 2004, with
TB/HIV activities funded by PEPFAR. TASC II TB is currently working at all levels of DOH in 5 provinces to
improve coordination of TB and HIV strategic and operational planning to integrate TB and HIV services into
primary health care; strengthen laboratory services to support comprehensive TB and HIV diagnosis and
care; develop new approaches to improve collaboration between TB and HIV programs; and improve
coordination between public and private sector to respond to the dual epidemic. TB/HIV strategy is
implemented using a collaborative approach to rapidly scale-up integrated TB/HIV services in targeted
provinces. Focus is on increasing access to counseling and testing (CT) for TB patients and early referral
for ARV therapy, and improve TB detection in HIV-infected people. TASC II TB will work closely with
PEPFAR partners involved in palliative care including basic health services for people living with HIV and
AIDS (PLHIV). The project will assist partners in integrating TB case management in basic health packages
for PLHIV. TASC II TB will also work with USAID partners providing services to children to integrate TB and
TB/HIV care algorithms in pediatric and well-baby care for HIV-infected infants and children. This will
include working with Medical Care Development International (MCDI), Integrated Primary Health Care
(IPHC), and other partners providing care and support for orphans and vulnerable children (OVC).
ACTIVITIES AND EXPECTED RESULTS:
ACTIVITY 1: Policy Development and Systems Strengthening
TASC II TB will continue working with National TB Program (NTP) and HIV and AIDS Unit at national and
provincial levels in developing and refining operational policies on TB/HIV coordinated activities. This
includes policies on treatment of co-infected patients. By providing on-going training and mentoring support,
TASC II TB will assist health facilities and health care workers to improve compliance with national
guidelines and protocols for screening, treatment and follow-up of TB/HIV co-infected patients. A cadre of
Master Trainers will be developed in each province to improve knowledge and skills of healthcare workers.
Managers and service providers will be trained to improve knowledge and skills in TB/HIV management and
service delivery issues; strengthen capacity of private providers and medical schemes to better manage co-
infected patients by ensuring that TB services are included as part of a comprehensive package of services;
improve HIV services in TB facilities by promoting provider-initiated CT, and appropriate staging and referral
of HIV-infected individuals. This will also ensure expansion of CT uptake among TB patients Referral
systems will be strengthened at district level between health and social services. Private practitioners will be
trained on MDR-TB and TB/HIV management. Systems will be put in place to ensure prompt diagnosis and
appropriate treatment. Links will also be developed between private practitioners and district TB
coordinators to ensure proper monitoring and reporting of TB/HIV co-infected patients. Funds will also be
used to ensure correct implementation of MDR/TB recording and reporting tools in all MDR-TB units in the
country. This will include training of healthcare workers and information officers on tools, and printing and
dissemination of these tools. TASC II TB will assist facilities and districts in reviewing performance data to
ensure all TB and HIV patients are screened for coinfections and co-infected patients are provided with
appropriate treatment and referrals.
ACTIVITY 2: Reduce Stigma and Discrimination
TASC II TB will support grassroots advocacy through CBOs/FBOs to counter stigma and promote a
supportive environment for people with TB and HIV by implementing community-based awareness
campaigns. The project will promote early diagnosis of TB among PLHIV by promoting routine TB screening
of HIV-infected patients and CT among TB patients. Small grants will be provided to local FBOs and CBOs
to integrate TB and HIV activities and provide nutritional support to individuals to encourage treatment
adherence, and also allow organizations to undertake advocacy and public education to create awareness
of TB/HIV dual infections and need for early screening. Home-based care groups will be funded to provide
adherence support to co-infected patients on TB and ARV drugs. Advocacy materials will be developed.
The project will fund local CBOs/NGOs for placing HIV counselors in all MDR-TB units to promote HIV
testing of all hospitalized TB patients. In addition, the project will also work with sessional doctors to stage
and manage co-infected patients and fast track access to ART for TB patients.
ACTIVITY 3: Strengthen Laboratory Services
The project will work with NTP and National Health Laboratory Services (NHLS) at service delivery level to
improve availability and quality of laboratory services critical for identifying TB among HIV-infected
individuals. Specific activities will include: 1) enhancing skills of laboratory staff in preparing and reading
smears; 2) placement of a laboratory quality assurance system to improve sensitivity and specificity of
sputum checking; and 3) development of a simple laboratory information system, linked with the electronic
TB Register (ETR) to track turn-around-time of specimens sent to laboratory. Working with NTP, NHLS,
World Health Organization (WHO) and Medical Research Council (MRC), laboratory TB policies and
guidelines will be updated to be in line with international standards and the STOP TB strategy. The project
will work with other partners to train districts and facilities on MDR-TB surveillance data collection and
reporting.
ACTIVITY 4: Monitoring and Surveillance
The project will work with NDOH to strengthen recording and reporting systems for TB and HIV by training
healthcare workers in implementation of revised TB and HIV registers, data collection and analysis, and on-
going problem solving functions. TB TASC will strengthen capacity of provincial, district and local service
area (LSA) health offices to establish functional HIV and AIDS, STI and TB (HAST) committees in order to
strengthen monitoring, supervision, and surveillance of TB and HIV by using an approach of continuous
Activity Narrative: feedback and mentoring of service providers. The project will also work with National DOH to strengthen
and improve TB and HIV monitoring through use of ETR. TASC II TB will work with DOH to monitor TB and
HIV programs as well as cross-referrals for TB/HIV and ARV treatment. Technical support will be provided
to health facilities and CBOs and FBOs in integrating TB and HIV with other health services to reduce
missed opportunities and improve continuum of care by promoting routine CT to TB patients and routine TB
screening for HIV people including pregnant women
ACTIVITY 5: Strengthen implementation of TB/HIV infection control policies and guidelines
TASC II TB will work with WHO and NTP to finalize the development of infection control guidelines for TB
program. This will be followed by training of primary health care managers and service personnel including
doctors, nurses and allied health workers on the implementation of the national policy and guidelines.
Information and education materials for TB infection control in work settings will be developed for health
care workers.
ACTIVITY 6: Strengthen surveillance of MDR/XDR-TB
TASC II TB will work with NTP as well as local universities to improve and expand surveillance of
MDR/XDR-TB in the country. Assistance will be provided to design a simple framework to collect and
analyze data on MDR/XDR patients in each province. In addition, mechanisms will be developed and
implemented for contact tracing of MDR patients to minimize risk of nosocomial transmission. Close
contacts of MDR/XDR-TB patients will be put under close surveillance and appropriate prophylactic
treatment if needed.
ACTIVITY 7: Promote Linkages with Palliative Care
TASC II TB will work with PEPFAR partners responsible for delivery of basic health care for PLHIV to
integrate TB screening, diagnosis, treatment and follow-up as part of their routine care and management of
HIV clients. PEPFAR partners will be helped to ensure all HIV infected clients are regularly screened for TB
and those with bacilli are put on TB treatment; and also in management of TB/HIV patients. TASC II TB will
provide training and follow-up support to these partners.
ACTIVITY 8: Strengthen TB and TB/HIV services for pediatrics
TASC II TB will work with USG partners working on child health issues to improve quality of services.
Partners will be trained in management of pediatric TB including suspecting and referring for TB diagnosis.
Key partners may include groups receiving USAID funds as well as other PEPFAR partners tasked with
OVC care and support.